US Court Grants MGI's Motion to Amend in Suit Against Illumina - 24 February 2021 07:36

SAN FRANCISCO, Feb. 24, 2021 /PRNewswire-Asianet/ -- A judge in the U.S. District Court for the Northern District of California has granted MGI's motion for leave to amend to add a new inequitable conduct defense of patent infringement lawsuit that Illumina filed against MGI in February 2020 (Case N...

  RedHill Biopharma Announces Planned Expansion of Opaganib Glob... - 24 February 2021 00:33

TEL AVIV, Israel and RALEIGH, NC, Feb. 23, 2021 /PRNewswire-AsiaNet / -- Following review of data from the U.S. Phase 2 study by the FDA, RedHill plans to expand the global Phase 2/3 study of orally-administered opaganib for severe COVID-19 to the U.S. The study has enrolled over 50% of the targeted 464 patients gl...

  INOVIO Announces First Subject Dosed in Phase 1B Clinical Tria... - 24 February 2021 00:00

PLYMOUTH MEETING, Pa., Feb. 23, 2021 /PRNewswire-AsiaNet/ -- -- Phase 1B clinical trial is first study for Lassa fever conducted in Africa -- Goal is for vaccine to be available for emergency use as stockpile product following Phase 2 -- Progress on INO-4500 reflects INOVIO's focus on an...

  Surgical Wait Times Technology Now Available in Australia and ... - 23 February 2021 08:00

SYDNEY, Feb. 23, 2021 /PRNewswire-AsiaNet/ -- -- Fastest Growing Canadian Health Technology Company Expands Into ANZ Wait times in both Australia and New Zealand are too long and how patients are admitted for surgery hasn't changed in decades. Unlike elsewhere, the process is unnecessarily...

  Los Angeles Lakers Name Hyperice Official Recovery Technology ... - 23 February 2021 01:00

EL SEGUNDO, Calif. and IRVINE, Calif., Feb. 23, 2021 /PRNewswire-AsiaNet/ -- -- First NBA Team Deal Returns the Recovery Technology Leader to its Southern California Roots The Los Angeles Lakers and Hyperice( https://c212.net/c/link/?t=0&l=en&o=3073861-1&h=2252051198&u=https%3A%2F%2Fhyperice.com%2F&a=Hyperice ) announce...

  Gan & Lee Announces New Partnership with International Diabete... - 22 February 2021 20:00

BEIJING and BRIDGEWATER, N.J., Feb. 22, 2021 /PRNewswire-AsiaNet/ -- Gan & Lee Pharmaceuticals Co., Ltd. (hereinafter referred to as Gan & Lee) (SANGHAI: 603087.SH), a global biopharmaceutical company, has announced a collaborative partnership with the International Diabetes Federation (IDF) that aims to suppor...

  Galderma online survey reveals essential COVID-19 mask wearing... - 19 February 2021 17:00

LAUSANNE, Switzerland, Feb. 19, 2021 /PRNewswire-AsiaNet/ -- - Although essential for public health, new online survey findings show that people with self-reported rosacea* may be experiencing worsening of symptoms due to mask wearing, further increasing the daily burden for people living with this chronic ...

  Regor Therapeutics Announces Completion of $90 Million Series ... - 19 February 2021 11:00

SHANGHAI, Feb. 19, 2021 /PRNewswire-AsiaNet/ -- Regor Therapeutics, a clinical stage biotechnology company dedicated to the discovery of innovative medicines to treat cancer, immune disorders and metabolic diseases, announces the successful completion of $90 million Series B financing. Found...

  RedHill Biopharma Announces First Patient Dosed in U.S. Phase ... - 17 February 2021 23:36

TEL AVIV, Israel and RALEIGH, N.C., Feb. 17, 2021 /PRNewswire-AsiaNet/ -- - The U.S. Phase 2/3 study with once-daily, orally-administered RHB-107 (upamostat) evaluates treatment of patients with symptomatic COVID-19 who do not require hospitalization - the vast majority of patients - RHB-107 is a novel serine protea...

  Launch of ESMO Virtual Plenaries Brings Rapid Access to Ground... - 17 February 2021 15:00

LUGANO, Switzerland, Feb. 21, 2021 /PRNewswire-AsiaNet/ -- Timely presentations of trial data will accelerate transition from research to practice ESMO, the leading organisation for medical oncology, launches an important new service for rapidly disseminating research to accelerate the transition of re...